EASD Highlights Isra Zaman21 Sept 2022 11:15 AM ISTDairy products in moderate amounts may protect against type 2 diabetes-but red and processed meat raise risk.Dairy products, especially low-fat ones...
NovoNordisk Gets CDSCO Panel Nod To Study anti-diabetic FDC Cagrilinitide,Semaglutide Dr. Divya Colin19 Sept 2022 6:00 PM ISTNew Delhi: Advising to submit the trial safety and efficacy data, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Semaglutide reduces diabetes risk by 61% in individuals with prediabetes or normal blood sugar levels Dr. Kamal Kant Kohli12 Sept 2022 11:29 AM ISTSemaglutide has recently been approved in US as an obesity treatment and has been provisionally approved to treat obesity in England. According to a...
Semaglutide, optimal therapy for type 2 diabetes with few side effects: Study Medha Baranwal2 Jun 2022 10:45 AM ISTEgypt: Tirzepatide, oral, and subcutaneous (SC) semaglutide have a favorable efficacy for type 2 diabetes treatment, according to results from a...
Oral semaglutide greatly reduces blood sugar and weight in type 2 diabetes patients: Study Medha Baranwal23 April 2022 9:15 AM ISTUSA: Treatment with oral semaglutide in type 2 diabetes patients results in consistently greater HbA1c reduction and weight loss, and more...
Liraglutide and semaglutide reduce MACE in diabetes patients regardless of PAD status: Study Medha Baranwal21 April 2022 9:00 AM ISTDenmark: Liraglutide and semaglutide may reduce major adverse cardiovascular events (MACE) in type 2 diabetes (T2D) patients regardless of their...
Novo Nordisk bags CDSCO Panel nod to study Semaglutide Roshni Dhar9 April 2022 10:29 AM ISTIn line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the Central Drugs...
Health Bulletin 8/April/2022 Roshni Dhar8 April 2022 5:36 PM ISTHere are the top health stories for the day:NMC launches online monitoring system for PG medical admissions, directs colleges to submit info With...
NovoNordisk gets CDSCO panel okay to study anti-diabetic drug Semaglutide Dr. Divya Colin5 April 2022 5:56 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the...
Semaglutide an effective alternative drug option to treat obesity MD Editorial Team24 Feb 2022 9:00 AM ISTObesity is a seriously neglected disease that is factually a multifactorial chronic disease affecting 650 million adults globally. It is associated...
Semaglutide to be efficient in weight loss in obese Patients Dr. Nandita Mohan7 Feb 2022 6:18 PM ISTObesity is a serious concern not only known to risk heart health but several other metabolic diseases are connected to obesity. Among adults with...
Novo Nordisk India unveils oral Semaglutide to treat diabetes Roshni Dhar25 Jan 2022 5:53 PM ISTDrug firm Novo Nordisk India on Thursday said it has launched a first of its kind diabetes treatment medication in the country. The company said it...
